Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo(R) (Telotristat Ethyl)

First -in-Class Oral Tryptophan Hydroxylase Inhibitor to be Considered for Approval in Europe for the Treatment of Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy Decision on Marketing Authorization Application Expected in Q3... Biopharmaceuticals, Regulatory Lexicon Pharmaceuticals, XERMELO, carcinoid syndrome diarrhea (Source: HSMN NewsFeed)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2txR24N
via IFTTT